Literature DB >> 16477029

Regulating activation of transplanted cells controls tissue regeneration.

Elliott Hill1, Tanyarut Boontheekul, David J Mooney.   

Abstract

Current approaches to tissue regeneration are limited by the death of most transplanted cells and/or resultant poor integration of transplanted cells with host tissue. We hypothesized that transplanting progenitor cells within synthetic microenvironments that maintain viability, prevent terminal differentiation, and promote outward migration would significantly enhance their repopulation and regeneration of damaged host tissue. This hypothesis was addressed in the context of muscle regeneration by transplanting satellite cells to muscle laceration sites on a delivery vehicle releasing factors that induce cell activation and migration (hepatocyte growth factor and fibroblast growth factor 2) or transplantation on materials lacking factor release. Controls included direct cell injection into muscle, the implantation of blank scaffolds, and scaffolds releasing factors without cells. Injected cells demonstrated a limited repopulation of damaged muscle and led to a slight improvement in muscle regeneration, as expected. Delivery of cells on scaffolds that did not promote migration resulted in no improvement in muscle regeneration. Strikingly, delivery of cells on scaffolds that promoted myoblast activation and migration led to extensive repopulation of host muscle tissue and increased the regeneration of muscle fibers at the wound and the mass of the injured muscle. This previously undescribed strategy for cell transplantation significantly enhances muscle regeneration from transplanted cells and may be broadly applicable to the various tissues and organ systems in which provision and instruction of a cell population competent to participate in regeneration may be clinically useful.

Entities:  

Mesh:

Year:  2006        PMID: 16477029      PMCID: PMC1413770          DOI: 10.1073/pnas.0506004103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Musculoskeletal conditions affect millions.

Authors:  Kenneth D McClatchey
Journal:  Arch Pathol Lab Med       Date:  2004-04       Impact factor: 5.534

2.  HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells.

Authors:  R Tatsumi; J E Anderson; C J Nevoret; O Halevy; R E Allen
Journal:  Dev Biol       Date:  1998-02-01       Impact factor: 3.582

3.  TNF-alpha is a mitogen in skeletal muscle.

Authors:  Yi-Ping Li
Journal:  Am J Physiol Cell Physiol       Date:  2003-04-23       Impact factor: 4.249

4.  Effect of fibroblast growth factor on the division and fusion of bovine myoblasts.

Authors:  D Gospodarowicz; J Weseman; J S Moran; J Lindstrom
Journal:  J Cell Biol       Date:  1976-08       Impact factor: 10.539

5.  Antifibrotic effects of suramin in injured skeletal muscle after laceration.

Authors:  Yi-Sheng Chan; Yong Li; William Foster; Takashi Horaguchi; George Somogyi; Freddie H Fu; Johnny Huard
Journal:  J Appl Physiol (1985)       Date:  2003-05-02

6.  The costs of musculoskeletal disease: health needs assessment and health economics.

Authors:  Deborah P Lubeck
Journal:  Best Pract Res Clin Rheumatol       Date:  2003-06       Impact factor: 4.098

7.  Muscle satellite (stem) cell activation during local tissue injury and repair.

Authors:  Maria Hill; A Wernig; G Goldspink
Journal:  J Anat       Date:  2003-07       Impact factor: 2.610

Review 8.  Myoblast transplantation: the current status of a potential therapeutic tool for myopathies.

Authors:  Daniel Skuk; Jacques P Tremblay
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

9.  ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells.

Authors:  Mina Ryten; Philip M Dunn; Joseph T Neary; Geoffrey Burnstock
Journal:  J Cell Biol       Date:  2002-07-22       Impact factor: 10.539

Review 10.  Skeletal muscle stem cells.

Authors:  Jennifer C J Chen; David J Goldhamer
Journal:  Reprod Biol Endocrinol       Date:  2003-11-13       Impact factor: 5.211

View more
  63 in total

1.  Alginate: properties and biomedical applications.

Authors:  Kuen Yong Lee; David J Mooney
Journal:  Prog Polym Sci       Date:  2012-01       Impact factor: 29.190

2.  Design and fabrication of a biodegradable, covalently crosslinked shape-memory alginate scaffold for cell and growth factor delivery.

Authors:  Lin Wang; Janet Shansky; Cristina Borselli; David Mooney; Herman Vandenburgh
Journal:  Tissue Eng Part A       Date:  2012-08-23       Impact factor: 3.845

Review 3.  Growth factor delivery-based tissue engineering: general approaches and a review of recent developments.

Authors:  Kangwon Lee; Eduardo A Silva; David J Mooney
Journal:  J R Soc Interface       Date:  2010-08-18       Impact factor: 4.118

4.  Injectable, Pore-Forming Hydrogels for In Vivo Enrichment of Immature Dendritic Cells.

Authors:  Catia S Verbeke; David J Mooney
Journal:  Adv Healthc Mater       Date:  2015-10-16       Impact factor: 9.933

Review 5.  Polymers to direct cell fate by controlling the microenvironment.

Authors:  R Warren Sands; David J Mooney
Journal:  Curr Opin Biotechnol       Date:  2007-10       Impact factor: 9.740

Review 6.  The development of high-throughput screening approaches for stem cell engineering.

Authors:  Ying Mei; Michael Goldberg; Daniel Anderson
Journal:  Curr Opin Chem Biol       Date:  2007-08-16       Impact factor: 8.822

Review 7.  Complexity in biomaterials for tissue engineering.

Authors:  Elsie S Place; Nicholas D Evans; Molly M Stevens
Journal:  Nat Mater       Date:  2009-06       Impact factor: 43.841

8.  Gas-foaming calcium phosphate cement scaffold encapsulating human umbilical cord stem cells.

Authors:  Wenchuan Chen; Hongzhi Zhou; Minghui Tang; Michael D Weir; Chongyun Bao; Hockin H K Xu
Journal:  Tissue Eng Part A       Date:  2011-12-09       Impact factor: 3.845

9.  Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation.

Authors:  Steven M Jay; Benjamin R Shepherd; James P Bertram; Jordan S Pober; W Mark Saltzman
Journal:  FASEB J       Date:  2008-05-01       Impact factor: 5.191

10.  Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors.

Authors:  Cristina Borselli; Hannah Storrie; Frank Benesch-Lee; Dmitry Shvartsman; Christine Cezar; Jeff W Lichtman; Herman H Vandenburgh; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.